VICTOR KRASNYKH to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications VICTOR KRASNYKH has written about Xenograft Model Antitumor Assays.
Connection Strength
0.027
-
Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT. Proc Natl Acad Sci U S A. 2011 Jan 25; 108(4):1603-8.
Score: 0.012
-
Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment. Cancer Res. 2004 Jun 15; 64(12):4319-27.
Score: 0.008
-
Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res. 2002 Aug 01; 62(15):4273-81.
Score: 0.007